July 6, 2020 / 11:16 AM / a month ago

BRIEF-Avrobio Announces New Patients Dosed In Gaucher Disease And Cystinosis Clinical Trials

July 6 (Reuters) - AVROBIO Inc:

* AVROBIO ANNOUNCES NEW PATIENTS DOSED IN GAUCHER DISEASE AND CYSTINOSIS CLINICAL TRIALS

* AVROBIO INC - FIRST PATIENT DOSED IN AVROBIO’S GLOBAL PHASE 1/2 CLINICAL TRIAL OF AVR-RD-02 FOR GAUCHER DISEASE TYPE 1

* AVROBIO INC - SECOND PATIENT DOSED IN INVESTIGATOR-SPONSORED PHASE 1/2 CLINICAL TRIAL OF AVR-RD-04 FOR CYSTINOSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below